Nutra Pharma, through its subsidiary ReceptoPharm,
has a pipeline of biopharmaceutical products under
development. These research and development pipeline
products consist of several novel therapies in
various stages of development to prevent and/or
treat multiple sclerosis, HIV/AIDS, adrenomyeloneuropathy,
herpes, rheumatoid arthritis and pain.
here to view the full pipeline.